Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Writing · Writing a Limitations Section

Study Limitations: Definition, Reporting Requirements and Structured Statements

The limitations section of a study is not a confession of failure. CONSORT and STROBE both require it as a specific, verifiable item, and reviewers read it as evidence that the authors understand the limits of their own evidence.

Pubrica AcademyWritten by a manuscript editor Reviewed bya research methodology reviewer Published10 October 2026 Last checked10 October 2026 Reading time7 minutes Sources10 peer-reviewed

A study limitation is any feature of a study's design, sample, measurement, or analysis that could plausibly affect how far its findings can be trusted or generalized. Limitations are not errors, and a strong limitations section is not an apology; it is a specific, bounded account of where the evidence is solid and where it is not, written so that readers can judge independently how much weight the findings deserve. Both of the major reporting guidelines for clinical research, CONSORT for randomized trials and STROBE for observational studies, include a specific checklist item requiring authors to discuss limitations, which signals that journals and reviewers treat this section as a required, assessable part of the paper rather than an optional closing gesture.

Learning objectives

  • Why a limitations section is a required checklist item under CONSORT and STROBE rather than an optional closing remark
  • The difference between a limitation and a weakness, and the implications of that distinction for phrasing
  • A structure for stating a limitation: its nature, its significance and the measures taken to address or bound it

Common misconceptions

  • “Admitting limitations makes a manuscript look weaker to reviewers.” CONSORT item 20 and STROBE item 19 both specifically require authors to discuss limitations, including sources of potential bias and imprecision, as a condition of complete reporting, and peer reviewers are trained to check for this section's presence and specificity rather than treating its absence as a sign of a stronger paper.

Distinguishing limitations from weaknesses and errors

A limitation is a constraint built into the study's own design choices, often made deliberately and for good reason, that bounds how its findings can be read: a single-center sample that may not generalize to other settings, a cross-sectional design that cannot establish causal order, a self-reported outcome measure that may carry recall bias, or a sample size set by feasibility rather than a formal power calculation. A weakness or an error, by contrast, is something that went wrong relative to the study's own stated plan, such as a protocol deviation, a measurement instrument that was later found to be miscalibrated, or a departure from the planned statistical analysis. The distinction matters for how the section is written: limitations are described as known, bounded constraints accepted at the outset of the design, while genuine deviations from a pre-registered or pre-specified plan need to be disclosed as such, not folded into the limitations section as though they were an inherent feature of the design1.

The limitations section as a required reporting item

The CONSORT 2010 statement for reporting randomized trials lists "limitations" as item 20 of its checklist, specifically asking authors to address trial limitations, sources of potential bias or imprecision, and, if relevant, multiplicity of analyses2. The STROBE statement for observational studies carries a parallel requirement at item 19, asking authors to discuss limitations of the study, taking into account sources of potential bias or imprecision, and to discuss both the direction and magnitude of any likely bias3. Because both guidelines are widely adopted by journals as a condition of submission or peer review, an editor or reviewer checking a manuscript against either checklist is specifically looking for this section, and its absence, or a version so vague it does not name a concrete constraint, is treated as incomplete reporting rather than simply a stylistic gap23.

A structure for stating each limitation

Editorial guidance on this section consistently recommends a three-part structure for each limitation stated: name the specific constraint, explain concretely how it could affect the findings (in which direction, and roughly how much if that can be estimated), and state what, if anything, was done to bound or mitigate it4. A limitation stated only as “this study had a small sample size” offers the reader little; a limitation stated as “the sample size of 64 was set by feasibility rather than a formal power calculation, which limits our ability to detect effects smaller than a moderate effect size, and the confidence intervals reported throughout should be read with this constraint in mind” gives the reader information that can be used to weigh the finding. STROBE's accompanying explanatory paper is explicit that a well-written limitations discussion should state both the likely direction of any bias (toward or away from the null) and, where estimable, its likely magnitude, rather than leaving the reader to infer whether a named limitation matters slightly or substantially3.

Common errors in limitations sections

The most common mistake is listing limitations generically without connecting any of them to the study's actual findings, a pattern that appears formulaic rather than reflecting methodological consideration. A second common mistake is burying a limitation that substantially changes how a key finding should be read inside a long list of minor ones, which in practice makes the serious constraint easy for a reader to overlook. A third is treating every limitation as equally damaging, when in practice some bound the findings only slightly while others materially change what can be concluded; editorial guidance on this section recommends ordering limitations by how much they affect the study's central claims, rather than by the order in which the authors identified them, so that the reader's attention is directed first to the most consequential constraints4.

Limitations in formal evidence-grading systems

A specifically stated limitation is not only a courtesy to the reader; it is one of the direct inputs into formal systems used to grade how much confidence a body of evidence deserves. The GRADE approach, widely used by guideline developers including the World Health Organization and Cochrane, explicitly treats "risk of bias" as one of five domains that can downgrade the certainty of evidence for a given outcome, and an author's own stated limitations are one of the sources a GRADE assessor draws on when judging that domain alongside the study's design and reported methods5. A limitations section that refers vaguely to “potential bias” without naming a specific, verifiable source gives a GRADE assessor, or any methodologist conducting a later systematic review that includes the study, less information than one that names the exact design feature responsible; this is a second, structural reason, beyond reviewer goodwill, to state limitations precisely rather than generically.

Worked examples of weak and strong limitation statements

A weak statement reads: “This study has several limitations, including a relatively small sample size and the use of self-reported data, which should be considered when interpreting the results.” It names two legitimate categories but gives the reader nothing actionable. A stronger statement addressing the same two issues reads: “Our sample of 64 participants was set by feasibility rather than a power calculation, so we had approximately 60% power to detect a moderate effect size and limited ability to detect smaller effects; null results for secondary outcomes should be read with this constraint in mind. Our primary outcome relied on self-reported symptom frequency rather than a clinician-administered instrument, which may have introduced recall bias toward more recent symptoms and could plausibly have inflated the association we report between symptom frequency and the exposure of interest.” The second version names the specific numbers, states a likely direction of bias, and specifies which of the paper's findings the limitation bears on, which is the level of specificity that the explanatory documents of both CONSORT and STROBE recommend23.

Evaluation of the limitations section in peer review

Editorial guidance aimed at peer reviewers themselves generally instructs them to check a limitations section against three questions: does it name the specific design or analytic features that constrain the findings, rather than a generic list; does it connect each named limitation to a specific result in the paper rather than stating it in the abstract; and does it avoid either overstating limitations to pre-empt criticism or omitting a limitation a careful reader would otherwise flag independently. Ioannidis's analysis of how limitations are handled across the published literature found that many papers' limitations sections read as formulaic additions rather than genuine engagement with a study's specific weaknesses, and recommended that journals and reviewers treat the specificity of this section as a concrete, checkable marker of a manuscript's overall methodological transparency rather than a stylistic formality6. A reviewer who finds a limitations section vague is often obliged to look elsewhere in the methods and results for the same information, which slows review and may be interpreted, fairly or not, as a sign that the authors have not fully considered the constraints of their own study.

Key points

Key points

A limitations section is a required checklist item under both CONSORT and STROBE, not an optional admission of failure. Each limitation should be stated specifically, with an explanation of the likely direction and size of its effect on the findings, and limitations should be ordered by importance rather than by the sequence in which they were identified.

Practical application

Practical application

  1. True limitations should be distinguished from deviations from the study plan. A deliberate design constraint belongs in the limitations section, whereas a departure from the pre-specified protocol or analysis plan requires separate, explicit disclosure.
  2. Each limitation should be written in three parts. The statement should name the specific constraint, state its likely direction and, where possible, the approximate size of its effect on the findings, and note the measures taken to bound or address it.
  3. Limitations should be ordered by their effect on the central claims. The constraint that most alters how a reader should weigh the main finding should be presented first, not last, and should not be buried in a long undifferentiated list.

Frequently asked questions

No. Quantifying the likely direction and size of bias is recommended wherever it can reasonably be estimated, but for limitations where that is not feasible, stating the plausible direction of effect and being explicit that the magnitude is unknown is still far more useful to a reader than a generic, unqualified mention.

Both CONSORT and STROBE place this item within the discussion section of a paper rather than requiring a standalone section, though many journals now ask for an explicitly labeled limitations subsection within the discussion for ease of review.

Yes, provided it is tied specifically to what was measured in this study and what effect that reliance could plausibly have on the particular findings being reported, rather than stated as a generic disclaimer disconnected from the paper's own results.

Reviewers and editors are specifically trained to check reporting guidelines like CONSORT and STROBE, and a limitations section that is specific and proportionate signals methodological self-awareness, which several editorial guides note is viewed favorably relative to a vague or missing one.

References

  1. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. read 10 October 2026. View on BMJ
  2. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. read 10 October 2026. View on BMJ
  3. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. read 10 October 2026. View on BMJ
  4. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297. read 10 October 2026. View on PLOS Medicine
  5. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. read 10 October 2026. View on BMJ
  6. Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-406. read 10 October 2026. View on Journal of Clinical Epidemiology
  7. Ioannidis JPA. Limitations are not Properly Acknowledged in the Scientific Literature. J Clin Epidemiol. 2007;60(4):324-329. read 10 October 2026. View on Journal of Clinical Epidemiology
  8. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291(20):2457-2465. read 10 October 2026. View on JAMA
  9. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010;40(1):35-53. read 10 October 2026. View on European Journal of Clinical Investigation
  10. Altman DG. The Scandal of Poor Medical Research. BMJ. 1994;308(6924):283-284. read 10 October 2026. View on BMJ

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). Study Limitations: Definition, Reporting Requirements and Structured Statements. Pubrica. https://pubrica.com/academy/case-reporting/what-are-the-study-limitations-and-how-should-they-be-stated/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Limitations Section Builder

Each limitation should be drafted in this three-part structure before the final discussion section is written.

[ ] Listed every design, sample, measurement, and analysis constraint separately from any protocol deviations
[ ] For each: named the specific constraint in one sentence
[ ] For each: stated its likely direction of effect on the findings (toward/away from the result shown)
[ ] For each: estimated its likely magnitude where possible, or stated plainly that magnitude is unknown
[ ] For each: noted what, if anything, was done to bound or mitigate it
[ ] Reordered the list so the limitation most relevant to your main finding appears first

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica's manuscript editing team reviews limitations sections against the CONSORT and STROBE checklist items directly, flagging vague or missing statements before submission rather than after a reviewer does.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Review of a limitations section against CONSORT and STROBE checklist items

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.